Frankincense for Inflammation: Does It Really Work?
Valerie Burke, MSNMaster of Science in Nursing; Geologist; Founder of Shungite Queen
Share
Frankincense resin contains compounds called boswellic acids, particularly AKBA and KBA, that researchers are studying for their role in inflammation. In laboratory studies they act on pathways different from NSAIDs: rather than blocking COX like ibuprofen, they target the 5-LOX enzyme and NF-κB signaling. Clinical research is most developed for knee osteoarthritis, and the form of frankincense you use matters enormously.
Updated October 27, 2026
Frankincense has been burned in temples and carried across ancient trade routes for thousands of years. The smoke was sacred, and the ritual was deliberate. But the part of frankincense that has researchers genuinely interested in 2026 isn't the aromatic plume rising from a censer - it's the resin itself, and the family of compounds locked inside called boswellic acids.
Frankincense inflammation research has accelerated around these molecules, which researchers are studying for joint, skin, gut and other concerns. The research is still developing, but early results are compelling.
This article covers the science without the fluff. You'll find a clear explanation of how frankincense works at the molecular level, what the research has looked at so far, how to pick the right form and dose, and safety considerations to be aware of. If you're exploring frankincense, this is a solid place to start. This article is educational and is not medical advice.
📌 The bottom line on the research: Boswellic acids from frankincense resin interact with key inflammatory pathways (5-LOX and NF-κB) in laboratory studies. In people, a 2020 meta-analysis of seven randomized trials (545 people with knee osteoarthritis) found that Boswellia extracts may relieve pain and stiffness and improve function, generally with good tolerability. Most trials are small, so larger studies are still needed, and the research on skin, gut and other concerns is earlier still.

How Boswellic Acids Work in Laboratory Studies
Boswellic acids are the active constituents in Boswellia resin, the plant source of frankincense. There are several of them, but two do most of the heavy lifting: AKBA (acetyl-11-keto-β-boswellic acid) and KBA (11-keto-β-boswellic acid). What makes them worth studying is that they hit inflammation through mechanisms that are genuinely different from the drugs most people reach for first.
The 5-LOX Pathway: Frankincense's Primary Target
AKBA binds directly to a selective non-substrate site on the 5-lipoxygenase (5-LOX) enzyme, blocking it through a non-redox, non-competitive mechanism (Poeckel & Werz, 2006; Ammon, 2016). This matters because 5-LOX is the enzyme responsible for producing leukotrienes, the inflammatory mediators tied to pain, swelling, tissue damage, and immune cell recruitment.
In laboratory studies, when AKBA blocks 5-LOX, leukotriene production drops, including LTB4 and 5-HETE, two of the most potent inflammatory signals in the body.
This is not the same mechanism of action as ibuprofen. NSAIDs block the COX pathway and suppress prostaglandins. Boswellic acids target the leukotriene pathway instead, which means they address a completely separate branch of the inflammatory cascade. That's why frankincense isn't a "natural ibuprofen" - it's operating on different chemistry altogether.
NF-κB Suppression and What It Means for Cytokine Levels
AKBA also inhibits NF-κB signaling by blocking IκB kinase-dependent phosphorylation of IκBα, according to mechanistic reviews summarizing AKBA's effects on the IKK/IκBα axis (Ammon, 2016; Abdel-Tawab et al., 2011).
In plain terms, in cell studies it keeps a key inflammatory switch from being flipped on. When NF-κB can't translocate to the nucleus, the genes that code for pro-inflammatory cytokines don't get expressed at the same levels. The downstream result, in these lab models, is reduced production of TNF-α, IL-1β, IL-6, and COX-2.
This multi-target profile is part of why researchers find Boswellia interesting. These are laboratory findings, though, and they alone don't tell us what happens in the human body.
Frankincense Inflammation Evidence: What Clinical Trials Show for Knee Osteoarthritis
Mechanism studies are encouraging, but the real question is whether any of this translates to real relief for real people. For knee osteoarthritis, the results thus far are encouraging, with the caveat that most trials are small. Larger confirmatory trials are still needed.
Key Osteoarthritis Trials and What They Found
The Kimmatkar 2003 trial enrolled 30 patients with knee osteoarthritis in a randomized, double-blind, placebo-controlled crossover design. Participants took 1,000 mg per day of Boswellia extract standardized to 40% boswellic acids for eight weeks.
The treatment group reported significant improvements in knee pain, swelling, flexion, and walking distance. Radiographs showed no structural change, and side effects were minor and gastrointestinal in nature.
The Sengupta 2008 trial scaled up to 75 patients and tested an AKBA-enriched extract called 5-Loxin at 100 mg per day and 250 mg per day over 90 days. Both doses improved pain and physical function significantly compared to placebo. The 250 mg group experienced faster symptom relief, and both doses reduced MMP-3 in synovial fluid, an inflammatory enzyme associated with joint degradation.
What a 2020 Meta-Analysis Concluded
A 2020 systematic review and meta-analysis of seven randomized trials, covering 545 people with knee osteoarthritis, found that Boswellia and its extracts may relieve pain and stiffness and improve function compared with controls. The authors suggested at least four weeks of use and called for larger, better-funded trials.
For Skin, Evidence Is Positive but Still Early
Joint research is the most developed area. For skin, the evidence is at an earlier stage.
Topical Boswellia and Skin Research
Small, early studies of Boswellia-based creams in people with psoriasis and dermatitis have reported improvements in scaling and redness, but these studies were limited and larger controlled trials are needed.
There is also a preclinical mouse study showing that topical frankincense extract reduced epidermal thickening and inflammatory infiltration in a psoriasis-like dermatitis model. Animal trial data is useful but is not a complete substitute for human trial evidence.
Gut Health and Beyond: Traditional Roots and Early Research
Frankincense has a long history of traditional use for digestive complaints, and leukotrienes are involved in some inflammatory bowel conditions, which is why researchers have looked at Boswellia here. The studies below are small and early.
When it comes to inflammatory bowel disease (IBD) and colitis, two studies deserve mention. The first study (Gupta et al 1997) involved patients with ulcerative colitis who were given 350 mg of a Boswellia gum resin preparation three times daily for six weeks. In this small, non-randomized study, 82 percent of those taking Boswellia went into remission, compared with 75 percent of a comparison group taking the prescription drug sulfasalazine.
In a second study (Gupta et al 2001), 20 patients with chronic colitis were given a Boswellia gum resin preparation (900 mg daily, divided into three doses) for six weeks. A whopping 18 of the 20 improved on one or more measures, and 14 went into remission, compared with 4 of 10 on sulfasalazine.
Although the findings are impressive, both studies were small and decades old, and larger modern trials are needed. If you have colitis or another inflammatory bowel condition, talk with your gastroenterologist before adding anything to your plan.
Researchers are also exploring Boswellia for other inflammatory and neurological concerns, but this work is preliminary and largely based on laboratory and animal studies. I explore this research further in my article for Ann Louise Gittleman.
Choosing the Right Form: Frankincense for Inflammation, Extracts, Oils, and Topicals Compared
Most people get tripped up here, and the wrong product choice leads to real disappointment. The form you choose and how it's made matters as much as the dose.

Things to Consider About Standardized Oral Extracts
Know that many studies have used extracts standardized to roughly 30 to 40% or more boswellic acids, so look for the percentage clearly stated on the label. Products that don't disclose BA content are hard to compare with the research.
Plain Boswellia resin tends to have poor oral bioavailability. Boswellic acids are lipophilic, poorly water-soluble, and don't absorb well in their unformulated state unless augmented with something to enhance absorption. As with curcumin, black pepper extract is sometimes added for this purpose.
How the Boswellia is extracted also matters. The vast majority is extracted with hexane. Choosing an extract made with organic ethanol avoids hexane residues. For example, this certified organic boswellia supplement is very pure and is extracted with organic ethanol, with 70% boswellic acids.
The Transdermal Option: Early Research
Boswellic acids are lipophilic and poorly water-soluble, which limits how well they are absorbed by mouth and also makes skin delivery a challenge. That is why researchers are actively developing skin-delivery systems for AKBA. In a 2026 rat study of arthritis, an AKBA microneedle system delivered more AKBA through the skin than AKBA cream, produced higher blood levels than the oral group, and reduced paw swelling and inflammatory markers (Priya et al., 2026). This was an engineered delivery system rather than a simple oil, so it shows promise for the skin route, not proof for any particular product.
Frankincense Essential Oil Is Not the Same as Boswellia Extract
This is a misconception that aromatherapy retailers and wellness bloggers repeat often enough that it's worth addressing directly. Frankincense essential oil is composed primarily of volatile aromatic compounds like alpha-pinene and other terpenes, the molecules responsible for the distinctive scent.
Boswellic acids, on the other hand, are non-volatile, resinous compounds not present in meaningful quantities in the essential oil fraction. Using frankincense essential oil as a substitute for a standardized Boswellia extract for pain and inflammation means the boswellic acid research does not apply, since the essential oil doesn't contain meaningful amounts of them.
📌 Be sure to read the fine print on any cream, oil or ointment that calls itself "frankincense cream" or "frankincense oil" because the vast majority contain ONLY the essential oil, therefore none of the boswellic acids.
Safe Use: Doses, Interactions, and When to Loop In Your Doctor
In clinical trials, Boswellia has been generally well tolerated, and recent meta-analyses in knee osteoarthritis found no excess of adverse events compared with controls (Zhang et al., 2025; Inprasit et al., 2025). That favorable profile doesn't mean it's without considerations. Become familiar with the common side effects, the documented interactions, and who needs extra caution.
Common Side Effects and Who Experiences Them
The most frequently reported side effects are gastrointestinal: nausea, loose stools, stomach cramping, heartburn, and bloating. Headache and weakness are occasionally reported. Most of these effects are mild and dose-related, meaning they often improve with dose adjustment or taking the supplement with food.
For topical use, skin reactions including rash and contact dermatitis are possible, particularly in people with sensitivities to tree resins.
Serious reactions are rare. Severe allergic responses, including facial or throat swelling, breathing difficulty, and hives, have been documented. If you experience any of those symptoms, stop use and seek medical care immediately. There are also individual case reports of unusual reactions, including one of mania and one of electrolyte disturbance, though these are isolated and not representative of typical use patterns.
Drug Interactions and Populations That Should Take Extra Care
The most documented interaction is with warfarin and other anticoagulants. Case reports describe elevated INR in warfarin-treated patients after starting Boswellia, with CYP2C9 inhibition proposed as a plausible mechanism, though that mechanism has not been definitively established and is based on case report data rather than controlled pharmacokinetic studies.
If you take a blood thinner, having a discussion with your physician before starting any Boswellia supplement is non-negotiable. NSAIDs present an overlapping mechanism concern, and immunosuppressants, particularly tacrolimus and cyclosporine, have a narrow therapeutic window that warrants caution due to potential CYP3A4 effects.
Pregnancy is another caution. Boswellia has traditionally been described as affecting uterine blood flow, so if you are pregnant or nursing, check with your healthcare provider before using it. People on immunosuppressant therapy should also consult their physician because it may interact in ways that are not fully characterized.
📌 In summary, special precautions exist for individuals who are taking blood thinners or immunosuppressants, are pregnant, or are allergic to tree resins.
The Bottom Line on Frankincense and Inflammation
The early frankincense inflammation research is compelling but still developing. The boswellic acid mechanisms have been well characterized in laboratory studies: 5-LOX inhibition reduces leukotriene production, and NF-κB suppression reduces cytokine output. The osteoarthritis trial data, from Kimmatkar 2003 and Sengupta 2008 through the 2020 meta-analysis, shows encouraging symptom improvement, even though the trials are small.
Topical Boswellia preparations are being studied for skin and other inflammatory concerns, though the research is early.
The practical steps are straightforward. Many studies used standardized extracts of roughly 30 to 40% or more boswellic acids, so check the label for the percentage, and look for gentle extraction methods and bioavailability enhancement. Studies typically ran at least four weeks, so give it time. If you take anticoagulants, immunosuppressants or NSAIDs regularly, talk to your doctor before you start.
Frankincense for inflammation works best as one component of a thoughtfully assembled natural health protocol, not as a standalone fix.
🌿 At Shungite Queen, the apothecary line is built around that same philosophy: carefully selected supplements and botanicals chosen to complement each other toward your broader health goals. In the Shungite Queen Apothecary, you will find several frankincense products made with a potent lab-verified boswellic acid extract.
Frankincense Resin Oil With 70% Boswellic Acid Extract →
❓Frequently Asked Questions
Does frankincense reduce inflammation?
In laboratory studies, boswellic acids (notably AKBA and KBA) from frankincense resin inhibit 5-LOX and NF-κB signaling, two pathways involved in inflammation. Clinical trials, especially in knee osteoarthritis, have reported promising results, but larger studies are needed.
How does frankincense work at the molecular level?
In lab studies, AKBA binds a selective non-substrate site on the 5-LOX enzyme, lowering leukotriene production including LTB4 and 5-HETE, and also inhibits NF-κB signaling by blocking IκB kinase-dependent phosphorylation of IκBα. The combined effect reduces pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and COX-2 expression, a multi-target profile that has captured researchers' interest.
Which conditions have the strongest clinical evidence for frankincense?
Knee osteoarthritis has been studied most, with consistent but mostly small trials. Research on skin, gut, and other concerns is earlier and varies in strength.
How do I pick the right form and dose of frankincense?
Look for Boswellia resin extracts standardized for boswellic acids with AKBA content clearly listed, since AKBA and KBA are the key active constituents. Dosing varies by preparation — most osteoarthritis trials used 1,000 mg daily of a standardized extract. For topical use, look for products made with a boswellic acid extract or resin, not just essential oil.
Are there safety concerns or drug interactions I should know about?
The most documented interaction is with warfarin and other anticoagulants — consult your physician before starting if you take blood thinners. Caution is also advised for those on immunosuppressants, those who are pregnant, and anyone with tree resin allergies. Side effects are generally mild and gastrointestinal in nature.
References
Studies cited in this article. Links go to the publisher or PubMed.
- Kimmatkar N, Thawani V, Hingorani L, Khiyani R. Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee: a randomized double blind placebo controlled trial. Phytomedicine. 2003;10(1):3-7. doi:10.1078/094471103321648593
- Sengupta K, Alluri KV, Satish AR, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee. Arthritis Research & Therapy. 2008;10(4):R85. doi:10.1186/ar2461
- Yu G, Xiang W, Zhang T, Zeng L, Yang K, Li J. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complementary Medicine and Therapies. 2020;20(1):225. doi:10.1186/s12906-020-02985-6
- Zhang Y, Gui Y, Adams R, et al. Comparative effectiveness of nutritional supplements in the treatment of knee osteoarthritis: a network meta-analysis. Nutrients. 2025;17(15). doi:10.3390/nu17152547
- Inprasit C, Bunyamahote S, Boonpattharatthiti K, et al. Evaluating the efficacy and safety of Curcuma longa, Boswellia serrata, and their mixed formulation in treating knee osteoarthritis: a systematic review and network meta-analysis. Complementary Therapies in Medicine. 2025;96:103256. doi:10.1016/j.ctim.2025.103256
- Gupta I, Parihar A, Malhotra P, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. European Journal of Medical Research. 1997;2(1):37-43. PubMed
- Gupta I, Parihar A, Malhotra P, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Medica. 2001;67(5):391-395. doi:10.1055/s-2001-15802
- Priya S, Kathuria H, Singhvi G. Hyaluronic acid-based dissolving microneedles for enhanced cutaneous delivery of 3-acetyl-11-keto-β-boswellic acid in rheumatoid arthritis: in vitro, ex vivo, and preclinical investigation. International Journal of Biological Macromolecules. 2026;356:151549. doi:10.1016/j.ijbiomac.2026.151549
References were checked against PubMed. This article is for education only and is not medical advice.